---
schema_version: "secwatch.filing_event.v1"
accession: "0001104659-24-113676"
form_type: "8-K"
ticker: "CVRX"
cik: "0001235912"
company_name: "CVRx, Inc."
filed_at: "2024-11-04T23:59:59+00:00"
generated_at: "2026-05-30T05:48:28.339334+00:00"
event_type: "regulatory"
sentiment: "positive"
materiality_score: 0.7
calibrated_materiality_score: 0.7
confidence: "high"
source: SEC EDGAR
---

# CMS assigns Barostim to APC 1580; payment ~$45,000 continues in 2025

## Summary
- Centers for Medicare and Medicaid Services assigned Barostim procedure to New Technology APC 1580.
- APC payment of approximately $45,000 will continue in 2025 per Medicare OPPS final rule.
- Announcement on November 4, 2024, confirms favorable reimbursement for CVRx's Barostim therapy.

## SEC filing metadata
- accession: 0001104659-24-113676
- form_type: 8-K
- ticker: CVRX
- cik: 0001235912
- company_name: CVRx, Inc.
- filed_at: 2024-11-04T23:59:59+00:00
- event_type: regulatory
- sentiment: positive
- materiality_score: 0.7
- calibrated_materiality_score: 0.7
- confidence: high
- sec_items: 8.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1235912/000110465924113676/0001104659-24-113676-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1235912/000110465924113676/tm2427376d1_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001104659-24-113676
- JSON: https://secwatch.observer/filing/0001104659-24-113676.json
- Plain text: https://secwatch.observer/filing/0001104659-24-113676.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.